Total number of shares and voting rights in Zealand Pharma as of June 30, 2025
Total number of shares and voting rights in Zealand Pharma as of June 30, 2025
Copenhagen, Denmark, June 30, 2025 – Zealand Pharma A/S ('the Company' or 'Zealand Pharma') (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announces, in accordance with section 32 of the Danish Capital Markets Act, the total number of shares and voting rights in the Company at the end of a calendar month during which changes to its share capital have occurred.
In Company Announcement No. 14 / 2025 dated June 6, 2025, Zealand Pharma announced a share capital increase due to the exercise of employee warrants. Following this announcement, the table below details the total number of shares and voting rights in Zealand Pharma as of June 30, 2025.
The Company's Articles of Association are available on the Company's website https://www.zealandpharma.com.
# # #
About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq: ZEAL) ('Zealand') is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with a number of pharmaceutical companies as well as commercial partnerships for its marketed products.
Zealand was founded in 1998 and is headquartered in Copenhagen, Denmark, with a presence in the United States. For more information about Zealand's business and activities, please visit www.zealandpharma.com.
Contact
Adam Lange (Investors)
Vice President, Investor Relations
[email protected]
Neshat Ahmadi (Investors)
Investor Relations Manager
[email protected]
Anna Krassowska (Investors and Media)
Vice President, Investor Relations & Corporate Communications
[email protected]
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
13 minutes ago
- Bloomberg
Bloomberg Surveillance: All-Time Highs
Watch Tom and Paul LIVE every day on YouTube: Bloomberg Surveillance hosted by Tom Keene & Paul Sweeney July 1st, 2025 Featuring: 1) Bob Michele, CIO: Fixed Income at JPMorgan Asset Management, joins for an extended discussion on the outlook for yields and why there could be more bond investment in 2025. The 10-year Treasury yield declined four basis points to 4.19% in the early morning as investors increased wagers on the scale of potential Federal Reserve interest rate cuts this year. 2) Cam Dawson, CIO at NewEdge Wealth, talks about equity all-time highs and raising the pain trade. US equity futures retreated slightly after the S&P 500 notched its best quarter since 2023, as investors monitor progress on trade talks and wrangling in Washington over President Trump's tax bill. 3) George Goncalves, Head: US Macro Strategy MUFG Securities, Americas, talks about the outlook for US economic growth should the tax bill pass and his economic projections for 2025 as the labor market shows signs of weakening. Investors are also watching for a slew of economic data, including PMI readings and the US job openings report, ahead of Thursday's nonfarm payrolls, and a discussion on monetary policy at the European Central Bank's annual retreat. 4) Michael Lasser, Equity Research Analyst: Consumer Hardline Staples at UBS, explores the potential ramifications of the bill on an aggregate consumer spending level, as well as the potential impacts for each consumer subsector and individual stocks. US consumer spending declined 0.3% in May, the most since the start of the year, indicating uncertainty around the Trump administration's economic policies is weighing on growth. 5) Lisa Mateo joins with the latest headlines in newspapers across the US, including a story from The Athletic on ESPN and MLB resuming broadcasting rights talks and a WSJ story on why the July 4th BBG may get more expensive.
Yahoo
31 minutes ago
- Yahoo
S&P/TSX composite down in late-morning trading, U.S. stock markets higher
TORONTO — Canada's main stock index was down in late-morning trading, weighed down by losses in the utility and technology sectors, while U.S. stock markets climbed higher. The S&P/TSX composite index was down 11.94 points at 26,845.17. In New York, the Dow Jones industrial average was up 1.37 points at 44,496.31. The S&P 500 index was up 12.95 points at 6,210.96, while the Nasdaq composite was up 158.18 points at 20,361.07. The Canadian dollar traded for 73.34 cents US compared with 73.30 cents US on Monday. The August crude oil contract was up 50 cents US at US$65.95 per barrel. The August gold contract was up US$3.50 at US$3,353.30 an ounce. This report by The Canadian Press was first published July 2, 2025. Companies in this story: (TSX:GSPTSE, TSX:CADUSD) The Canadian Press Sign in to access your portfolio
Yahoo
37 minutes ago
- Yahoo
Teledyne Technologies Earnings Preview: What to Expect
With a market cap of around $24 billion, Teledyne Technologies Incorporated (TDY) is a diversified industrial company that provides advanced enabling technologies across a range of high-growth markets, including aerospace and defense, environmental monitoring, and medical imaging. The company operates internationally through four key segments: Digital Imaging, Instrumentation, Aerospace and Defense Electronics, and Engineered Systems. The Thousand Oaks, California-based company is slated to announce its fiscal Q2 2025 earnings results on Wednesday, Jul. 23. Ahead of this event, analysts expect TDY to report an adjusted EPS of $5.02 per share, a 9.6% growth from $4.58 in the year-ago quarter. It has exceeded Wall Street's earnings expectations in the past four quarters. Microsoft Stock Is Headed for $4 Trillion. Is It Too Late to Buy MSFT Here? Is UnitedHealth Stock a Buy, Sell, or Hold for July 2025? Is Palantir Stock a Buy at New Record Highs? Our exclusive Barchart Brief newsletter is your FREE midday guide to what's moving stocks, sectors, and investor sentiment - delivered right when you need the info most. Subscribe today! For fiscal 2025, analysts expect the defense and aerospace industry supplier to report adjusted EPS of $21.47, marking a growth of 8.8% from $19.73 in fiscal 2024. Moreover, adjusted EPS is anticipated to grow 11.2% year-over-year to $23.87 in fiscal 2026. Shares of Teledyne Technologies have gained 31.7% over the past 52 weeks, outpacing the broader S&P 500 Index's ($SPX) 12.6% return and the Technology Select Sector SPDR Fund's (XLK) 9.7% rise over the same period. Teledyne Technologies reported Q1 2025 results on Apr. 23. The company reported net sales of $1.5 billion, a 7.4% increase year-over-year and adjusted EPS came in at $4.95, surpassing analysts' estimates. Additionally, Teledyne's digital imaging segment, a key contributor to defense-related demand, grew 2.2% to $757 million, reflecting ongoing geopolitical tensions and strong demand for military sensors and cameras. However, despite the strong results, shares of TDY fell 2.7% that day. Analysts' consensus view on Teledyne Technologies stock remains bullish, with a "Strong Buy" rating overall. Out of 10 analysts covering the stock, eight recommend a "Strong Buy," one "Moderate Buy," and one "Hold." As of writing, TDY is trading below the average analyst price target of $562.20. On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on
